About Navega Therapeutics
Navega Therapeutics is a private company based in San Diego, California. It has reported $1,300,000 raised in one offering on Form D since January 2026. Its chief executive is Ana Moreno.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 30, 2026 | $1,300,000of $2.5M target | 8 | $162K | Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Navega Therapeutics's Form D filed Jan 30, 2026.
RS
Randy Socol
Executive officer
FA
Fernando Aleman
Executive officer and director
AM
Ana Moreno
Chief Executive Officer and director